Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07430345Phase 2Recruiting
A Phase 2 trial of buprenorphine extended-release injection in bone fracture, sponsored by Cooper University Health Care. Started May 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07430345.